Search Results 8291-8300 of 33328 for oral
... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...
Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...
A phase II study to evaluate antitumor activity of oral cMET inhibitor INC280 in adult patients with EGFR wild-type, advanced non-small cell lung cancer (NSCLC) ...
Best Oral Presentation AwardSociety of British Neurological Surgeons. 2006. PAIRO Resident Teaching AwardResidents and Interns Association of Ontario. 2005.
Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...
... oral) and/or antibiotics. One of the two required moderate exacerbations has to require the use of systemic corticosteroids. **Severe exacerbations are ...
Second Runner Up for Oral Presentation in Clinical ResearchMayo Clinic Arizona Academic Excellence Day, Department of Education Administration. 2007.
Associate Board ExaminerOral Boards, American Board of Surgery. 2009 - 2015. Medical Directorinstitution. 2009 - 2012. Executive Committee MemberSurgical and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.